Molecular Cancer apeutics linical Development l Targeting of CDK and Tropomyosin Receptor Kinase ilies by the Oral Inhibitor PHA-848125 , an Agent Ther Broad-Spectrum Antitumor Efficacy
暂无分享,去创建一个
A. Isacchi | C. Mercurio | F. Colotta | M. Ciomei | D. Ballinari | F. Fiorentini | W. Pastori | M. Brasca | A. Galvani | R. Alzani | J. Moll | N. Avanzi | V. Patton | G. Locatelli | N. Amboldi | Albanèse | Pesenti | io Festuccia | Roletto